Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3398456 | Clinical Microbiology and Infection | 2008 | 4 Pages |
Abstract
ABSTRACTThe decreasing prevalence of anti-Toxoplasma antibodies in Europe has re-opened the question of the appropriateness of serological screening during pregnancy. A study of 3426 pregnant women, resident in the Legnano area of Italy, revealed that the IgG seroprevalence according to ELISA was 21.5%, and that of IgM according to ELISA and enzyme-linked fluorescent assay was 1.2% and 0.9%, respectively. The incidence of infection, estimated on the basis of IgG avidity, was 0.9%. These results confirm a decrease in the prevalence of IgG, but indicate a high incidence of infection, thus suggesting that screening for anti-Toxoplasma antibodies during pregnancy should be maintained.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
M. De Paschale, C. Agrappi, P. Clerici, P. Mirri, M.T. Manco, S. Cavallari, E.F. Viganò,